Supplementary Table 5 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models
Fabian F. Pusch,Heathcliff Dorado García,Robin Xu,Dennis Gürgen,Yi Bei,Lotte Brückner,Claudia Röefzaad,Jennifer von Stebut,Victor Bardinet,Rocío Chamorro Gonzalez,Angelika Eggert,Johannes H. Schulte,Patrick Hundsdörfer,Georg Seifert,Kerstin Haase,Beat W. Schäfer, Marco Wachtel,Anja A. Kühl,Michael V. Ortiz,Antje M. Wengner,Monika Scheer,Anton G. Henssen crossref(2024)
摘要
Supplementary Table 5 lists the quantifications of IHC markers in EWS and OS PDX.
更多查看译文
AI 理解论文
溯源树
样例